Home Angel Investors Tympany Medical raises €3.5m for specialised ear surgery device – The Irish...

Tympany Medical raises €3.5m for specialised ear surgery device – The Irish Times

0
43

Sign up for alerts from The Irish Times
Just click on “Allow Notifications” on the message appearing on your browser to activate them.
We will send you a quick reminder in the future, in case you change your mind.



Tympany Medical co-founder Dr Liz McGloughlin
Co Galway-based medtech company Tympany Medical has raised €3.5 million in a seed investment round from backers that include the venture arm of the Mayo Clinic, which has been consistenly ranked as the best hospital in the US.
Tympany has developed the world’s first specialised minature endoscope for ear surgery called OtoVU.
Previously, more cumbersome endoscopes have been used in procedures rather than ones designed specifically to assist surgeons operating on the intricate detail of the human ear.
With some 660,000 surgeries performed a year in the US and Europe, and over 450 million people experiencing hearing loss globally, Tympany has a sizeable market opportunity.
The seed investment is intended to be used to help secure FDA approval for its miniature device and to expand the team.
The financing was led by the Atlantic Bridge University Bridge Fund, and includes significant investment from Ascentifi, alongside Western Development Commission, Enterprise Ireland, Mayo Clinic Ventures, Xenium Capital and a number of expert angel investors.
Tympany was founded by Dr Liz McGloughlin and Rory O’Callaghan in 2018 as a spinout from the BioInnovate Ireland programme at the National University of Ireland, Galway.
Dr McGloughlin said OtuVU is expected to be available commercially some time in 2022.
The start-up has been supported by Enterprise Ireland’s Commercialisation Fund programme as well as by EIT Health through its Innovation Project and Amplifier programmes. It has also been awarded support via the State’s Disruptive Technology Innovation Fund.
 Subscribe.

Monday to Friday
See a sample
Get the latest business news and commentary from our expert business team every weekday
Sign up
Subscribe
Support
Irish Times products & services
About us
Our partners




Invalid email or password.
Unfortunately USERNAME we were unable to process your last payment. Please update your payment details to keep enjoying your Irish Times subscription.

source

NO COMMENTS

LEAVE A REPLY

Please enter your comment!
Please enter your name here